| Financial Year |
March 31 2023 |
| Monetary Funds |
283,987,816.57 |
| Held-for-trading Financial Assets |
6,552,740.72 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,014,296,104.27 |
| Advances to Suppliers |
43,428,696.30 |
| Other Receivables |
37,379,356.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
644,323,155.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,596,576.36 |
| Total Current Assets |
2,086,893,858.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,527,269.43 |
| Investment Properties |
-- |
| Fixed Assetes |
28,829,448.41 |
| Under-construction Projects |
280,230,978.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,922,227.00 |
| R&D expenses |
49,918,288.79 |
| Goodwill |
98,832,910.24 |
| Long-Term Deferred and Prepaid Expenses |
10,611,243.62 |
| Deferred Income Tax Assets |
59,731,530.83 |
| Other Non-Current Assets |
31,722,274.74 |
| Sub-Total of Non-Current Assets |
773,293,493.10 |
| Total Assets |
2,860,187,351.79 |
| Short-Term Loans |
348,017,172.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
71,615,998.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,566,113.33 |
| Taxes Payable |
63,824,487.08 |
| Interest Payable |
1,493,462.24 |
| Dividend Payable |
-- |
| Other payables |
37,139,989.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,613,370.86 |
| Other Current Liabilities |
985.76 |
| Sub-Total of Current Liabilities |
721,757,218.11 |
| Long-term Loans |
431,871,834.35 |
| Bonds Payable |
382,077,071.65 |
| Long-Term Accounts Payable |
449,722.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,440,438.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
853,059,699.06 |
| Total Liabilities |
1,574,816,917.17 |
| Paid-In Capital(Or Share Stock) |
462,181,807.00 |
| Capital Surplus |
346,917,001.76 |
| Surplus Reserve |
42,148,868.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
282,588,471.53 |
| Minority Stockholder's Interest |
55,390,258.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,229,980,175.97 |
| Owner's Equity（Stockholder's Equity） |
1,285,370,434.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,860,187,351.79 |
